InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: MrGlasses post# 37205

Friday, 08/06/2021 11:04:10 AM

Friday, August 06, 2021 11:04:10 AM

Post# of 64226
1000's of American Companies qualify for Covid grants these days, and TSOI's clearly 1 of them, as more than factually evidenced/proven by the FDA's Phase III approval of their novel JadiCell IP solution fully detailed & outlined in yesterdays news.

Plus, logic also strongly suggests that with "so many" already biotech sector big board executives serving right TSOI's advisory board & executive mgmt rosters, that "all" of them have been speaking to BIG pharma companies they already serve on Boards of, and/or already know which big pharma company would make the optimal JadiCell collaborative partner instead of TSOI being foolish enough to go it alone.

In fact, today's CEO Dixon post about applying for EUA is yet another strong tell that a pending big pharma collaborative partner announcement is most likely pending, as why wouldn't TSOI partner with a big pharma firm to save lives and cure the scar tissue on the lungs many covid long haulers are already currently suffering from, with a multitude more covid infected people around the world to soon be suffering from scar tissue damaged lungs to come right!

And for anyone claiming TSOI's a dilution play it bears noting that TSOI is a full SEC Reporting PubCo that files fully audited financials and has a green shield verified DTC deposited tradable float verified on OTC Markets each month by the transfer agent directly to OTC Markets.

And absolutely "none" of the distinguished biotech sector executives surrounding CEO Dixon would ever let him claim no dilution required to pay for JadiCell Phase III if it wasn't true...because all of them are only heavily involved with TSOI because they "all" are already convinced their direct involvement with TSOI is going to "enhance" their already distinguished biotech sector careers right!

Dr. Ichim alone serves as BOD or Advisory Board member on 7 big board biotech PubCo's if memory serves for an example of the sheer quality of established bio sector executives right alongside CEO Dixon at this precise juncture, and 1 can only imagine who they've already identified as the best/most optimal collaborative partner to aid and assist them in getting their novel JadiCell IP solution to the world ASAP.

Here's the latest updated DTC deposited float as of this week by the way:

Held at DTC
1,129,681,369
08/03/2021

And here's what it was back in May which was 3 months ago cheers:

Held at DTC
1,075,956,980
05/19/2021



Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News